Search for: "GlaxoSmithKline LLC" Results 81 - 100 of 179
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
3 Mar 2017, 8:32 am by Lawrence B. Ebert
GlaxoSmithKline LLC,713 F.3d 1090, 1095 (Fed. [read post]
27 Jul 2018, 10:24 am by Andrew Hamm
GlaxoSmithKline LLC v. [read post]
14 Feb 2022, 9:38 am by Dennis Crouch
by Dennis Crouch GlaxoSmithKline LLC v. [read post]
31 Jul 2011, 12:10 pm by Josh Myers
Myers is the owner and President of Myers Injury Law, LLC and a founding partner of Schultz & Myers, LLC. [read post]
6 May 2022, 8:10 am by Dennis Crouch
Cir. 2021), en banc denied at GlaxoSmithKline LLC v. [read post]
29 Mar 2024, 10:04 am by Rebecca Tushnet
GlaxoSmithKline Consumer Healthcare Holdings (US) LLC, --- F.Supp.3d ----, 2024 WL 348821, No: 4:20-cv-09077-JSW (N.D. [read post]
13 Aug 2021, 6:43 am by Rebecca Tushnet
GlaxoSmithKline Consumer Healthcare Holdings (US) LLC, No. 20-cv-09077-JSW,  2021 WL 3524047 (N.D. [read post]
26 Jan 2021, 8:11 am by Tina G. Yin Sowatzke, Pharm.D.
Amgen, GlaxoSmithKline (GSK) and a group of intellectual property professors filed a trio of amicus briefs placing their support behind Idenix, warning that the future of innovation was on the line. [read post]
15 Nov 2010, 6:58 am by Mark Zamora
During the Committee's follow-uphearing on the recall of infant, children, and adult OTC products by McNeil ConsumerHealthcare, LLC (McNeil), a number of bipartisan questions were raised regarding theinvolvement of the U.S. [read post]
17 Nov 2010, 6:00 am
Recently, manufacturing problems at McNeil Consumer Healthcare, LLC's Puerto Rico facility led to an unusual "silent recall" of Motrin® (ibuprofen). [read post]
15 May 2023, 9:59 am by Jonathan H. Adler
GlaxoSmithKline LLC, which presented the question: "If a generic drug's FDA-approved label carves out all of the language that the brand manufacturer has identified as covering its patented uses, can the generic manufacturer be held liable on a theory that its label still intentionally encourages infringement of those carved-out uses? [read post]
26 Mar 2010, 7:23 am by Greenberg & Bederman
Further, the Staff Report mischaracterizes and distorts the efforts that GlaxoSmithKline LLC (“GSK”) took to continue to monitor the safety and efficacy of its diabetes medication. [read post]
28 Sep 2010, 3:14 pm by Kelly
(Patent Docs) Herceptin (Trastuzumab) – US: Patent infringement complaint: GlaxoSmithKline LLC v. [read post]
6 Oct 2010, 4:22 am by Kelly
(profitability through simplicity) US: Yeda Appeals Board decision favoring Abbott in TBP-II interference (Holman’s Biotech IP Blog) US: Jury finds Scruggs wilfully infringed Monsanto patents, awards at least $9 million in damages (Holman’s Biotech IP Blog) US: Marcy Kaptur’s bill to create a compulsory license for patented seeds: the Seed Availability and Competition Act of 2009 (KEI) US: Glaxosmithkline Biologicals seeks review of BPAI decision concerning isolated… [read post]
16 Mar 2021, 6:00 am by Jason Rantanen
To the Open Source Hardware (OSHW) community, the Federal Circuit’s October opinion in the ongoing appeal of GlaxoSmithKline LLC v. [read post]